- Home
- MNKD vs OPRA Comparison
MNKD vs OPRA Comparison
Compare MNKD & OPRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- OPRA
- Stock Information
- Founded
- MNKD 1991
- OPRA 1996
- Country
- MNKD United States
- OPRA Norway
- Employees
- MNKD N/A
- OPRA N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- OPRA Computer Software: Prepackaged Software
- Sector
- MNKD Health Care
- OPRA Technology
- Exchange
- MNKD Nasdaq
- OPRA Nasdaq
- Market Cap
- MNKD 1.5B
- OPRA 1.6B
- IPO Year
- MNKD 2004
- OPRA 2018
- Fundamental
- Price
- MNKD $5.76
- OPRA $19.59
- Analyst Decision
- MNKD Buy
- OPRA Strong Buy
- Analyst Count
- MNKD 6
- OPRA 5
- Target Price
- MNKD $8.92
- OPRA $24.80
- AVG Volume (30 Days)
- MNKD 1.7M
- OPRA 429.0K
- Earning Date
- MNKD 02-26-2025
- OPRA 02-27-2025
- Dividend Yield
- MNKD N/A
- OPRA 7.96%
- EPS Growth
- MNKD N/A
- OPRA 142.24
- EPS
- MNKD 0.08
- OPRA 1.78
- Revenue
- MNKD $267,200,000.00
- OPRA $447,818,000.00
- Revenue This Year
- MNKD $44.15
- OPRA $21.46
- Revenue Next Year
- MNKD $19.65
- OPRA $15.79
- P/E Ratio
- MNKD $72.34
- OPRA $11.46
- Revenue Growth
- MNKD 51.35
- OPRA 17.82
- 52 Week Low
- MNKD $3.47
- OPRA $10.11
- 52 Week High
- MNKD $7.63
- OPRA $22.50
- Technical
- Relative Strength Index (RSI)
- MNKD 48.03
- OPRA 48.32
- Support Level
- MNKD $5.32
- OPRA $20.67
- Resistance Level
- MNKD $5.65
- OPRA $22.50
- Average True Range (ATR)
- MNKD 0.18
- OPRA 0.94
- MACD
- MNKD 0.03
- OPRA 0.00
- Stochastic Oscillator
- MNKD 81.48
- OPRA 46.90
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About OPRA Opera Limited
Opera Ltd is a world-wide internet brand with a large, engaged and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. The newest addition of browsers is the beta release of a Web3-centric browser for PC and mobile which is tailored for crypto enthusiasts.